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2VO ratsAging related reduction in cerebral bloodﬂow (CBF) has been linkedwith neurodegenerative disorders including
Alzheimer's disease and dementia. Experimentally, a condition of chronic cerebral hypoperfusion due to reduced
CBF canbe induced by permanent bilateral occlusion of common carotid arteries (2-vessel occlusion, 2VO) in rats.
Since oxidative stress, leading to neuronal apoptosis and death, is one of the mechanisms, which is thought to
play a signiﬁcant role in chronic degenerative neurological disorders, the present study was planned to assess
the ROS status by measuring the levels of anti-oxidant enzymes that might occur during chronic cerebral hypo-
perfusion. Antioxidant enzymes namely glutathioneperoxidase (GPx), superoxide dismutase (SOD), and catalase
were measured in the brain tissue at eight weeks of 2VO induction in rats. Results show signiﬁcantly elevated
levels of GPx, SOD, and catalase enzymes as compared with the control group. It is possible that compensatory
rise in antioxidant enzymes occurs in response to increased oxidative stress following ischemic insult.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The vascular hypothesis of Alzheimer's disease (AD)whichwas ﬁrst
proposed by de La Torre and Mussivand (1993), suggested that aging is
themost fundamental risk factor for AD. This hypothesis is based on the
observation that cerebral perfusion normally declines during aging and
worsens in the presence of long standing vascular risk factors that fur-
ther lower CBF until attaining a critical threshold level of cerebral hypo-
perfusion. In chronic cerebral hypoperfusion bloodﬂow is insufﬁcient to
meet the metabolic demands of brain tissue (de la Torre, 2010). It has
beenwell established that aging andAlzheimer's disease (AD) including
dementia are associated with reduced cerebral blood ﬂow (Farkas and
Luiten, 2001). Data from Doppler and clinical studies show that both
the regional cerebral perfusion rate and the ﬂow velocity in the cerebral
resistance vessels decrease in aging humans and AD patients as com-
pared to age-matched healthy control (Claus et al., 1998; Krejza et al.,
1999; Vriens et al., 1989). Similarly, Aanerud et al. (2012) reported re-
sults from PET studies in healthy volunteers, a decrease with age in
CBF and cerebral metabolic rate of oxygen consumption (CMRO2) and
increase in oxygen extraction fraction (OEF) in areas known to be vul-
nerable in AD and PD..
. This is an open access article underFor the establishment of chronic cerebral hypoperfusion (CCH) (as it
occurs in human aging and AD) permanent bilateral common carotid
artery occlusion (BCCAO) (2-vessel occlusion, 2VO) of rats has been in-
troduced (Farkas et al., 2007). 2VO rats have been used successfully as a
model of vascular dementia to study the role of cerebral hypoperfusion
in neurodegenerative processes (Jing et al., 2015). However, the CBF
(cerebral blood ﬂow) pattern in 2VO rats is not identical to that occur-
ring in aging or dementia in humans. Following induction of occlusion
in 2VO rats, the CBF drops sharply and then begins to normalize after
about 3 months due to compensatory and adaptive mechanisms.
There is, however, a relatively long period of time (8 weeks to
12 weeks) during which the cerebral hypoperfusion in 2VO rats is
comparable to that in aging humans (Choy et al., 2006). Cerebral hypo-
perfusion in 2 VO rats induced neuronal cell death in hippocampus, ce-
rebral cortex, thewhitematter areas and the visual system (Farkas et al.,
2004; Liu et al., 2006; Ohtaki et al., 2006), and learning andmemory im-
pairment (Cechetti et al., 2012; Xi et al., 2014), aswell as acceleration of
cerebral amyloid angiopathy and promotion of cortical microinfarct
(Okamoto et al., 2012).
Chronic cerebral hypoperfusion-induced neurodegeneration is asso-
ciatedwith the generation of reactive oxygen species (ROS), which is le-
thal to neurons at high concentration. The ROS in turn initiate lipid
peroxidation, generating lipid peroxides that are degraded to reactive
aldehyde products such as malondialdehyde (MDA) (Muralikrishna
and Hatcher, 2006). Along with the increase in lipid peroxidation, thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ase (Cu/Zn-SOD) or the concentrations of non-enzymatic antioxidants
such as glutathione (GSH) decrease (Nita et al., 2001). However, in-
creased lipid peroxidation and a decrease in antioxidants enzymes
have primarily been associated with reperfusion after ischemia, which
is very gradual in permanent 2VOmodel due to the ﬂow compensation.
There are suggestions that oxidative injury plays a role in Alzheimer's
disease, Parkinson's disease, multiple sclerosis, schizophrenia, mito-
chondrial encephalopathies and brain injury due to ischemia and
reperfusion (Mittal, 1999). However, not much is known about the pos-
sible role of oxidative stress in the pathogenesis of chronic cerebral
hypoperfusion-induced neurodegeneration in 2VO rats.
The present study was, therefore, designed to evaluate the ROS sta-
tus bymeasuring the levels of antioxidant enzymes like glutathioneper-
oxidase (GDx), superoxide dismutase (SOD), and catalase in chronic
cerebral hypoperfusion-induced neurodegeneration in 2VO rats.
2. Methods
The study was conducted onWistar rats of either sex, weighing 200
to 250 g. The rats were obtained from the Universiti Sains Malaysia and
were kept in standard plastic cages. During oneweek of acclimatization,
rats were randomly distributed in pairs per cage. They were maintained
on ad libitum food and water with 12/12 h light/dark cycle. All proce-
dureswere compliedwith the guidelines of theU.S. Public Health Service
and NIH concerning the care and use of animals for experimentation as
well as the guidelines and recommendations of Malaysian National Ani-
mal Welfare Foundation. The IIUM Ethical Committee approved all ex-
perimental procedures.
After one week of acclimatization, rats were randomly divided into
two groups. Group A (n = 7) rats served as a control and they were
not subjected to 2VO. Group B (n = 7) rats were subjected to perma-
nent, bilateral common carotid arteries occlusion (2VO).
2.1. 2VO procedure in rats
Surgery was done as described before (Cechetti et al., 2010). Brieﬂy,
under full aseptic conditions, atropine sulfate (0.1 mg/kg) was given
intramuscularly as a pre-anesthetic agent to prevent any respiratory
distress. Rats were anesthetized with intraperitoneal injection of keta-
mine (90 mg/kg) and xylazine (10 mg/kg). A 2 cm ventral midline
skin incisionwasmade in the neck area just above the sternal bone. Fol-
lowing gentle tweezing of neckmuscles, the carotid artery inside the ca-
rotid sheath was located on both sides and the common carotid arteries
were carefully separated from the vagus nerve after carefully cutting the
carotid sheath. The common carotid arteries were doubly ligated by
sterilized silk suture just below the bifurcation into internal and exter-
nal carotid arteries and the arteries were cut between the two ligatures.
The incision was stitched and the wound treated with povidone iodine
(‘Betadine’) solution. The body temperature was maintained through-
out the surgical procedure and recovery period by heat lamp until full
recovery from the general anesthesia. Intraperitoneal injection of
buprenorphine (0.05 mg/kg) was administered to rats, which did not
start water drinking on recovery from anesthesia due to pain in neck
muscles tweezing during 2VO surgery.
At 8th week of 2VO surgery, Group A and Group B rats were
sacriﬁced by euthanization with ether. The brain was quickly dissected
out and rinsed with phosphate buffer saline (pH 7.4). The whole brain
was crudely minced with a spatula and divided into three portions.
Each portion was weighed and further processed. Three of the samples
were homogenized respectively in 5–10 ml/g of 50 mM cold Tris–HCl
buffer containing 5 mM EDTA and 1 mM DTT (pH 7.5) for GPx; 5–
10 ml/g cold 20 mM HEPES buffer containing 1 mM EGTA, 210 mM
mannitol and 70 mM sucrose (pH 7.2) for SOD; and 5–10 ml/g of cold
50 mM potassium phosphate buffer containing 1 mM EDTA (pH 7.0)
for catalase estimation. Samples were centrifuged at 10,000× g for15 min at 4 °C for GPx and catalase, 1500× g for 5 min at 4 °C for SOD.
Supernatant was collected and stored at−80 °C.
2.2. Determination of antioxidant enzymes
GPx, SOD, and catalase enzymes were estimated with the help of
Cayman Chemicals assay kits, USA. For GPx (catalogue no. 703102),
SOD (catalogue no. 706002), and catalase (catalogue no. 707002) in-
structions from the respective catalogues were strictly adhered to.
2.3. Statistical analysis
Data were analyzed using Predictive Analytics Software (PASW ver-
sion 18.0) and are presented here as mean ± SEM values. Comparison
between the groups was done by independent t-test (Gaussian). Differ-
ences were designated as signiﬁcant when p b 0.05 at 95% conﬁdence
interval.
3. Results
Antioxidant enzymes, GPx, SOD, and catalase activities were found
to be signiﬁcantly increased at 8weeks after permanent bilateral carotid
artery occlusion in rats. Themean value of GPx activity in the 2VO group
was found to be 306.18 ± 2.85 nmol/min/ml, which was signiﬁcantly
higher (p b 0.001) when compared with the control group (241.67 ±
1.94 nmol/min/ml). Similarly, the mean SOD and catalase enzyme
activities were signiﬁcantly higher (0.159 ± 0.001 U/ml and 9.49 ±
0.25 nmol/min/ml, respectively; p b 0.001) as compared with the
control group (0.113 ± 0.004 U/ml and 6.64 ± 0.431 nmol/min/ml, re-
spectively; p b 0.001) as shown in Table 1.
4. Discussion
It is noteworthy that vascular dementia is the secondmost common
cause of senile dementia (Kalaria et al., 2008). Oxidative stress has long
been linked to the neuronal cell death that is associated with neurode-
generative disorders, including dementia. In AD brain, the levels of anti-
oxidant enzymes were found to be decreased, with an associated
increase in protein oxidation, lipid peroxidation, DNA oxidation, and
ROS formation, strongly suggesting a role for oxidative stress in the
pathogenesis of AD (Butterﬁeld and Laderback, 2002; Markesbery,
1997; Sultana et al., 2006). Whether oxidative stress is a primary
cause or merely a consequence of associated neuronal cell death is still
an open question.
Permanent bilateral ligation of the common carotid arteries in rats is
a chronic cerebral hypoperfusion model, which results in signiﬁcant re-
duction of cerebral blood ﬂow and neuronal damage. There is abundant
evidence showing that free radicals are capable of mediating neuronal
degeneration and death, and are possibly involved in the pathogenesis
of neuronal death in neurodegenerative diseases (Muralikrishna and
Hatcher, 2006; Sultana et al., 2006).
We already have reported a highly signiﬁcant increase in the mean
MDA concentration in 2VO rats as compared to the control group at
8th week (Saxena et al., 2011). In the present study, antioxidant en-
zymes namely GPx, SOD, and catalase activities were evaluated and
compared with that of control group at 8th week after induction of
2VO in rats. Our results clearly show a signiﬁcant increase in antioxidant
enzymes namely GPx, SOD, and catalase in the brain. It is possible that in
response to increased oxidative stress following ischemic insult, com-
pensatory rise in antioxidant enzymes occurs. Similarly, Liao et al.
(2004) reported that chronic cerebral hypoperfusion resulted in a sig-
niﬁcant increase in SOD, GPx activities, and MDA content compared to
sham-operated group in rats (Liao et al., 2004). However, Mracskó
et al. (2010) did not ﬁnd any changes in the antioxidant enzyme
MnSOD (Mracskó et al., 2010), while in our study a signiﬁcant increase
in SOD (and catalase)was seen at 8weeks after 2VO. However, Mracskó
Table 1
Mean values of GPx, SOD, and catalase in the control and 2VO groups.
Test parameters Control
(n = 7)
2VO
(n = 7)
Mean ± SEM Mean ± SEM df t-stat P-value
GPx activity
(nmol/min/ml)
241.668 ± 1.941 306.179 ± 2.846 12 18.723 b0.001
SOD activity
(U/ml)
0.113 ± 0.004 0.159 ± 0.001 12 11.213 b0.001
Catalase activity
(nmol/min/ml)
6.637 ± 0.431 9.486 ± 0.255 12 5.68 b0.001
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oxidative enzymes that follow hypoperfusion after 2VOwherein chang-
es in one direction seen in the early phase may be reversed or normal-
ized later on for a particular enzyme. Moreover, changes in oxidative/
antioxidantmechanisms in one area (e.g. the cortex) do not correspond
to changes in another area (hippocampus) implying thereby that differ-
ent areas of the brain react in different ways and with varying time
course. Since Mracsko et al. studied MnSOD levels only in the cortex
and hippocampal regionswhile our data is from thewhole brain, chang-
es in other areas of the brain could possibly have contributed to this
difference.
Increased lipid peroxidation and a decrease in antioxidants enzymes
have primarily been associated with reperfusion after ischemia, which
is very gradual in permanent 2VOmodel due to the ﬂow compensation.
However, in chronic cerebral hypoperfusion there might be an increase
and/or decrease in antioxidant enzymes levels at different time inter-
vals after induction of 2VO in rats. Few and conﬂicting reports are avail-
able regarding the status of antioxidant enzymes in 2VO rats. Therefore,
more studies are needed to ﬁrmly establish the exact role of antioxidant
enzymes in chronic cerebral hypoperfusion in rats. These preliminary
data require conﬁrmation, but it is currently considered that 2VO cre-
ates a permanent ischemic/oligemic condition serious enough to sustain
continuous oxidative stress (probably in both the acute and chronic
phases), which could very well be the reason for the persistent and pro-
gressive neuronal damage.
To date, there are no speciﬁc drugs to cure, delay or prevent vascular
dementia. Hence, therapeutic strategies to modulate lipid peroxidation
early throughout the course of the disease may be promising in slowing
or possibly preventing neurodegenerative disorders.
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